瘤学家经常从竞争对手公司获得行业支付吗?
Helen M Keetley1, Ziad Zakaria1, Grace Gallagher1
1Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY, USA.
The oncologist
|January 9, 2026
概括
多家制药公司向医生支付的费用并不能取消利益冲突. 接受竞争性癌症药物的行业支付的瘤学家显示出改变了处方模式,表明了潜在的偏见.
科学领域:
- 在瘤学瘤学.
- 制药行业 制药行业 制药行业
- 医学伦理 医学伦理
背景情况:
- 对瘤学家的药品支付可能会影响处方习惯.
- 医生可能认为,来自竞争药品公司的付款可以消除利益冲突.
- 这项研究调查了瘤学家为多种竞争性癌症药物获得支付的频率.
研究的目的:
- 为了确定瘤学家在多种竞争性癌症药物上获得行业支付的频率.
- 评估从多家竞争药品制造商收到支付是否平衡了潜在的偏见.
主要方法:
- 使用的CMS Part D Prescribers文件 (2017-2019) 和开放支付数据.
- 包括医疗瘤学家在具有多个竞争对手的类中开处方药.
- 分析了对0,1,2,或3种竞争药物的支付收据,并与处方行为相关联.
主要成果:
- 少数瘤学家在同一类中的三种竞争药物都获得了支付 (1.6%用于EGFR抑制剂,25.3%用于BCR-ABLTKI,34.3%用于CDK4/6抑制剂).
- 由多家公司支付的瘤科医生与未支付的同行相比,表现出不同的处方模式.
- 具体的例子包括增加的ribociclib与palbociclib处方和减少的dasatinib处方对于所有三家制药公司所支付的处方.
结论:
- 虽然所有竞争公司的支付总体上并不频繁,但它们在某些药物类别中占少数.
- 来自多家竞争药品制造商的行业支付似乎没有中和利益冲突.
- 在收到竞争支付的瘤科医生和没有收到竞争支付的瘤科医生之间,处方模式不同.
更多相关视频
相关概念视频
01:27Nursing Ethical Principles II
2.1K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.1K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
02:18Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K